D'Amore Healthcare Offers Ketamine Therapy

HUNTINGTON BEACH, Calif., March 9, 2020 /PRNewswire/ -- Cutting-edge therapies for depression are currently in high demand. Depression affects more than 264 million people worldwide. "Spravato" is the latest technique being utilized to counteract treatment-resistant depression. Spravato is a variation of Ketamine Therapy that is administered in a nasal spray as opposed to previous intravenous ketamine infusions. D'Amore Healthcare is a Mental Health Treatment Center located in Huntington Beach, California that has adopted Spravato as a viable treatment for Major Depressive Disorder.

Chronic depression is a prevalent blood pressure health crisis in the United States. Psychiatric experts and patients have conflicting views on whether common antidepressant medications (like SSRIs, SNRIs, and TCAs) are genuinely effective in the long run. Tricyclic Antidepressants are the oldest of these FDA approved drugs. In cases of treatment-resistant depression, the efficacy of these prescriptions remains controversial.

A new therapy exists for the treatment of Major Depressive Disorder. Recent research strongly suggests that its ability to treat depression could prove to be revolutionary. With tremendous support, Ketamine therapy was approved by the Food and Drug Administration for the treatment of depression in March of 2019.

D'Amore Healthcare recently became licensed to administer Ketamine Therapy in the less-invasive form of a nasal spray called Spravato. Spravato treatments are an innovative method for lessening depressive symptoms. At their Huntington Beach Treatment Center, D'Amore provides Ketamine Therapy that is overseen by trained medical professionals. Spravato can be used to help people suffering from clinical depression, bipolar disorder, and other mental health disorders.

Clients who have undergone Ketamine Therapy have reported significant improvements in their depression symptoms. Some people report experiencing these improvements hours after their treatments. Studies suggest that Ketamine's positive effects are the result of brain synapses growth.

Ketamine therapy involves a once-a-week administration via a nasal spray. These treatment sessions must always be supervised by a medical professional. There is a fine line between using Ketamine as a therapeutic agent and abusing it. People who take Ketamine recreationally often abuse it and experience hallucinations and shocks to their central nervous system. Conversely, patients who ingest Ketamine and its molecular cousin, Esketamine, under the oversight of a medical doctor report miraculous recoveries.

D'Amore Healthcare is a mental health treatment center that specializes in the subacute treatment of a variety of disorders including anxiety, mood, psychotic, personality, and substance use. Many of these mental health issues are co-occurring. This makes sustained recovery that much more challenging. Simply treating depression alone can be tricky. With the implementation of Ketamine therapy, we may begin to see a decline in depression rates.

Please visit our website at damorehealthcare.com or call (714) 375-1110 for more information on this and other important subjects.

View original content to download multimedia:http://www.prnewswire.com/news-releases/damore-healthcare-offers-ketamine-therapy-301019344.html

SOURCE D'Amore Healthcare